<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29771335</article-id>
<article-id pub-id-type="pmc">6454515</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddy189</article-id>
<article-id pub-id-type="publisher-id">ddy189</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Loss of fragile X protein FMRP impairs homeostatic synaptic downscaling through tumor suppressor p53 and ubiquitin E3 ligase Nedd4-2</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Kwan Young</given-names>
</name>
<xref ref-type="aff" rid="ddy189-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jewett</surname>
<given-names>Kathryn A</given-names>
</name>
<xref ref-type="aff" rid="ddy189-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chung</surname>
<given-names>Hee Jung</given-names>
</name>
<xref ref-type="aff" rid="ddy189-aff1">1</xref>
<xref ref-type="aff" rid="ddy189-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsai</surname>
<given-names>Nien-Pei</given-names>
</name>
<xref ref-type="aff" rid="ddy189-aff1">1</xref>
<xref ref-type="aff" rid="ddy189-aff2">2</xref>
<xref ref-type="corresp" rid="ddy189-cor1"></xref>
<!--<email>nptsai@illinois.edu</email>-->
</contrib>
</contrib-group>
<aff id="ddy189-aff1"><label>1</label>Department of Molecular and Integrative Physiology, School of Molecular and Cellular Biology</aff>
<aff id="ddy189-aff2"><label>2</label>Neuroscience Program, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA</aff>
<author-notes>
<corresp id="ddy189-cor1">Correspondence to be addressed at: 407 South Goodwin Avenue, Urbana, IL 61801, USA. Tel: +1 2172445620; Fax: +1 217331133; Email: <email>nptsai@illinois.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>15</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date iso-8601-date="2018-05-16" pub-type="epub">
<day>16</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>8</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>27</volume>
<issue>16</issue>
<fpage>2805</fpage>
<lpage>2816</lpage>
<history>
<date date-type="received">
<day>06</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>07</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Â© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="oup-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="ddy189.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Synaptic scaling allows neurons to homeostatically readjust synaptic strength upon chronic neural activity perturbations. Although altered synaptic scaling has been implicated to underlie imbalanced brain excitability in neurological disorders such as autism spectrum disorders and epilepsy, the molecular dysregulation and restoration of synaptic scaling in those diseases have not been demonstrated. Here, we showed that the homeostatic synaptic downscaling is absent in the hippocampal neurons of <italic>Fmr1</italic> KO mice, the mouse model of the most common inherited autism, fragile X syndrome (FXS). We found that the impaired homeostatic synaptic downscaling in <italic>Fmr1</italic> KO neurons is caused by loss-of-function dephosphorylation of an epilepsy-associated ubiquitin E3 ligase, neural precursor cell expressed developmentally down-regulated gene 4-2, Nedd4-2. Such dephosphorylation of Nedd4-2 is surprisingly caused by abnormally stable tumor suppressor p53 and subsequently destabilized kinase Akt. Dephosphorylated Nedd4-2 fails to elicit 14-3-3-dependent ubiquitination and down-regulation of the GluA1 subunit of AMPA receptor, and therefore impairs synaptic downscaling. Most importantly, using a pharmacological inhibitor of p53, Nedd4-2 phosphorylation, GluA1 ubiquitination and synaptic downscaling are all restored in <italic>Fmr1</italic> KO neurons. Together, our results discover a novel cellular mechanism underlying synaptic downscaling, and demonstrate the dysregulation and successful restoration of this mechanism in the FXS mouse model.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Simons Foundation</named-content>
<named-content content-type="funder-identifier">10.13039/100000893</named-content>
</funding-source>
<award-id>SFARI #336605</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health(NIH)</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>R01NS105615</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="12"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>